Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
01/2007
01/30/2007CA2302411C Improved method for preventing crystal formation in a scopolamine transdermal device
01/25/2007US20070020177 Radiometal complex compositions
01/24/2007CN1902197A Improved aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
01/18/2007US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis
01/17/2007EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
01/17/2007CN1897947A Muscarinic acetylcholine receptor antagonists field of the invention
01/16/2007US7164027 Aralkyl ester soft drugs
01/11/2007WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors
01/11/2007WO2007003522A1 Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them
01/11/2007US20070010557 Novel amides useful for treating pain
01/11/2007US20070009432 Boat tropanes
01/10/2007EP1741703A1 Pyridone derivative
01/10/2007EP1741430A1 Remedy for psychoneurotic diseases
01/10/2007EP1740570A2 Novel gamma secretase inhibitors
01/10/2007EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
01/10/2007EP1740177A2 Muscarinic acetylcholine receptor antagonists
01/10/2007CN1893948A Muscarinic acetylcholine receptor antagonists
01/09/2007US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
01/09/2007CA2236578C Dopamine transporter imaging agent
01/04/2007WO2006108127A3 Crystalline form of a quinolinone-carboxamide compound
01/03/2007EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
01/03/2007EP1737860A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
01/03/2007EP1737853A1 3-(diheteroarylmethylene)-8-azabicyclo¬3.2.1|octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo¬3.2.1|octane derivatives
01/03/2007EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
01/03/2007EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
01/03/2007EP1737823A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
01/03/2007CN1890239A Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
01/03/2007CN1890237A Method for producing n-substituted 3beta-aminonortropanes
12/2006
12/28/2006WO2006117299A9 Novel crystalline forms of tiotropium bromide
12/28/2006WO2006117299A2 Novel crystalline forms of tiotropium bromide
12/28/2006CA2612491A1 Tricyclic opioid modulators
12/27/2006EP1736467A1 Novel sulfonamide derivative
12/27/2006EP1736156A1 STABILIZED 4-AMINO-5-CHLORO-N-¬(1R,3r,5S)-8-METHYL-8- AZABICYCLO¬3.2.1|OCT-3-YL|-2-¬1-METHYLBUT-2-YNYLOXY|-BENZAMIDE CONTAINING COMPOSITION
12/27/2006EP1735304A1 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
12/27/2006EP1735286A1 Tetrahydro-indazole cannabinoid modulators
12/27/2006EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
12/27/2006CN1886135A Phenyl-piperazine derivatives as modulators of muscarinic receptors
12/27/2006CN1291986C Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
12/21/2006WO2006135715A1 Benztropinamine analogs as dopamine uptake inhibitors
12/21/2006WO2006134486A2 Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists
12/21/2006WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
12/21/2006WO2006134021A2 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
12/21/2006WO2006133802A1 N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists
12/21/2006US20060286099 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006US20060286098 Derived from cocaine linked to cholera B toxin; antibodies; for treatment of cocaine addiction; immunization
12/21/2006US20060286097 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006US20060286096 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006US20060286095 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006US20060286094 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006CA2612299A1 Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists
12/21/2006CA2609577A1 Benztropinamine analogs as dopamine uptake inhibitors
12/20/2006EP1732923A2 Muscarinic acetylcholine receptor antagonists
12/20/2006EP1732552A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
12/20/2006EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/20/2006EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006CN1882582A Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
12/20/2006CN1880319A Tropane derivatives as CCR5 modulators
12/14/2006WO2006131525A1 3 -aryloxy- 8 -aza-bicyclo [3.2.1.] oct- 6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/14/2006US20060280736 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/14/2006CA2620986A1 3 -aryloxy- 8 -aza-bicyclo [3.2.1.] oct- 6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/13/2006EP1731518A1 Cyclic amine compound and pest control agent
12/13/2006EP1392676B1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
12/12/2006US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006US7148236 Modulate neurotransmission by promoting the release of neurotransmitters such as acetylcholine, dopamine and norepinephrine; thio-bridged aryl derivatives; treats central and autonomic nervous system disorders
12/07/2006WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006WO2005100350A8 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
12/07/2006US20060276503 Novel process salts compositions and use
12/07/2006US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006US20060276482 Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists
12/07/2006CA2610671A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/06/2006EP1727812A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006EP1572668A4 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
12/06/2006EP1397135B1 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways
12/06/2006CN1875020A Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
12/06/2006CN1875019A Novel crystalline anhydride with anticholinergic effect
12/06/2006CN1874775A 4-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (VR1) for the treatment of pain
12/06/2006CN1288154C Technical synthesis method for producing tropenol
11/2006
11/29/2006EP1726590A1 Cycloalkanopyridine derivative
11/29/2006EP1572207A4 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
11/23/2006WO2006076317A3 Aminophenyl derivatives as selective androgen receptor modulators
11/23/2006US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006US20060264419 Substituted pyrazoles
11/23/2006CA2608240A1 Multicyclic compounds and methods of their use
11/22/2006CN1867330A N-substituted azacycles
11/16/2006WO2006105035A3 Muscarinic modulators
11/16/2006WO2006021559A8 Method for producing tiotropium salts and silicon derivatives as intermediates
11/16/2006US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/15/2006EP1720859A2 Chemokine receptor antagonists
11/15/2006EP1453511B1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
11/15/2006CN1861598A Preparation process of thiatro bromoaminium anhydrous compound
11/14/2006CA2128493C Aminobenzoic acid derivatives
11/09/2006WO2006117300A2 Crystalline forms of tiotropium bromide
11/09/2006CA2606552A1 Crystalline forms of tiotropium bromide
11/09/2006CA2606549A1 Crystalline forms of tiotropium bromide
11/08/2006EP1718643A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists
11/07/2006US7132541 Microbiocides
11/07/2006US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/02/2006US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity
11/01/2006CN1856485A Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
10/2006
10/31/2006US7129235 Amides useful for treating pain
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 53